drugset / Trial / NCT02927847
Neuroimaging Reward, Behavioral Treatment, and Smoking Cessation
Phase 1/2
Completed
35 enrolled
Maggie M Sweitzer, PhD
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupSingle-blindBasic science
Summary
The goal of this study is to evaluate the effects of a smoking cessation intervention combining behavioral treatment with low nicotine cigarettes on neuroimaging measures of reward function and smoking cessation outcomes. The results of this study will provide information about mechanisms contributing to smoking and smoking cessation and will help to guide future treatment studies.
Timeline
- Start
- 2017-02-01
- Primary completion
- 2021-05-28
- Completion
- 2022-05-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Nicotine | Unknown | 21 mg | Other |
| Background | SPECTRUM Nicotine Research Cigarettes | Unknown | 0.03 mg | Other |
Indications
No indication recorded.